TNF and rheumatoid arthritis: Recent advancements in pharmacologic therapies, including inhibitors for tumor necrosis factor (TNF)-α, interleukin (IL)-6 and Janus kinases, T cell co-stimulation blockers, and B cell depletion agents significantly improve the disease state and functional impairment of RA patients [2].